| Prognostic factor |
HR |
95% C.I. |
P-value |
|
| IGF-1R expression |
3.01 |
1.48 - 6.11 |
P=0.002 |
| EGFR expression |
1.10 |
0.65 - 1.86 |
P=0.736 |
| HER2 expression |
1.11 |
0.59 - 2.11 |
P=0.743 |
| Performance status 0 (n=42) (vs. PS 2) |
0.19 |
0.05 - 0.72 |
P=0.014 |
| Performance status 1 (n=42) (vs. PS 2) |
0.26 |
0.07 - 0.98 |
P=0.047 |
| Pathological stage II (n=11) (vs. stage IV) |
0.26 |
0.12 - 0.57 |
P<0.001 |
| Pathological stage III (n=23) (vs. stage IV) |
0.39 |
0.21 - 0.72 |
P=0.003 |
| Intestinal type tumor |
0.24 |
0.13 - 0.42 |
P<0.001 |
|